ÂÜÀòÂÒÂ×

George Doyle is an experienced professional with a robust background in the pharmaceutical industry. Doyle served as the Head of Global Quality Assurance and was the President and CEO of Boehringer-Ingelheim Ben Venue during a long tenure at Boehringer Ingelheim from 1996 to 2011. Prior to that, Doyle was the President and CEO of Boehringer Ingelheim, Roxane, and held the position of Site Head and Head of Production at Novartis from 1994 to 1996. Early in the career, Doyle gained experience as a manager at Bristol Myers Squibb from 1981 to 1989. Educationally, Doyle holds a Master of Business Administration from the University of Evansville, a Bachelor of Pharmacy from the Medical University of South Carolina, and a Bachelor's degree in Zoology/Animal Biology from Clemson University.